Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramPresident & Immunovant CEOCIK 0001801917
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 11 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $7.26M 200.0K sh | Nov 5, 2026 traded Nov 3, 2026 | |
Venker EricPresident & Immunovant CEO |
Open-market sale · 10b5-1 plan |
| SELL |
| $7.32M 200.0K sh |
| Oct 30, 2026 traded Oct 28, 2026 |
| 7 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $501K 14.1K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $6.52M 185.9K sh | Oct 22, 2026 traded Oct 20, 2026 |
| 14 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $5.08M 153.8K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 5 | Venker EricPresident & Immunovant CEO | Option exercise · 10b5-1 plan | M | $770K 200.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 10 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $1.55M 46.2K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 0 | Venker EricPresident & Immunovant CEO | Option exercise · 10b5-1 plan | M | — 200.0K sh | Jun 26, 2026 traded Jun 24, 2026 |
| 23 | Venker EricPresident & Immunovant CEO | Open-market sale · 10b5-1 plan | SELL | $5.92M 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 0 | Venker EricPresident & Immunovant CEO | Option exercise · 10b5-1 plan | M | — 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 9 | Venker EricPresident & Immunovant CEO | Option exercise · 10b5-1 plan | M | $770K 200.0K sh | Apr 22, 2026 traded Apr 20, 2026 |
| 21 | Venker EricDirector, Chief Executive Officer | Grant or award | A | — 232.3K sh | Apr 9, 2026 traded Apr 7, 2026 |
| 9 | Venker EricDirector, Chief Executive Officer | Grant or award | A | — 336.0K sh | Apr 9, 2026 traded Apr 7, 2026 |